Franck Toledo

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 12, 2025
Mutant p53 as a Therapeutic Target: The Report of Its Death Was an Exaggeration.

Franck Toledo

|Apr 14, 2025
Oncogenic and teratogenic effects of Trp53Y217C, an inflammation-prone mouse model of the human hotspot mutant TP53Y220C.

Sara Jaber, Eliana Eldawra, Jeanne Rakotopare

|Sep 19, 2024
Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas.

Anne Fajac, Iva Simeonova, Julia Leemput

|Oct 14, 2023
p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.

Jeanne Rakotopare, Franck Toledo

|Sep 04, 2023
A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities.

Jeanne Rakotopare, Vincent Lejour, Carla Duval

|Apr 18, 2020
Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance.

Eléonore Toufektchan, Vincent Lejour, Romane Durand

Pageof 2

Frequent Collaborators

4 joint publications

Vincent Lejour

2 joint publications

Jeanne Rakotopare

2 joint publications

Antonin Morillon

2 joint publications

Boris Bardot